Light-chain amyloidosis
1 paper
Trial sponsors
Company1 trialPhase 127 people
Funding
1 grant since 2023National Heart, Lung, and Blood InstituteUS$819k
Latest
1 in 12 monthsAHA Scientific Sessions 2025 Abstract
SGLT2 Inhibitors Reduce Mortality and Improve Cardiac Biomarkers in Cardiac Amyloidosis: A Systematic Review and Meta-Analysis
Meta-analysis of observational studiesSGLT2 inhibitors